Browse > Article

The Effects of Sustained Release Growth Hormone in the Repair of Neurological Deficits in Rats with the Spinal Cord Injury  

Kim, Min Su (Department of Plastic and Reconstructive Surgery, College of Medicine, Dong-A University)
Heo, Jung (Department of Plastic and Reconstructive Surgery, College of Medicine, Dong-A University)
Kwon, Yong Seok (Department of Plastic and Reconstructive Surgery, College of Medicine, Dong-A University)
Lee, Keun Cheol (Department of Plastic and Reconstructive Surgery, College of Medicine, Dong-A University)
Kim, Seok Kwun (Department of Plastic and Reconstructive Surgery, College of Medicine, Dong-A University)
Publication Information
Archives of Plastic Surgery / v.35, no.3, 2008 , pp. 235-242 More about this Journal
Abstract
Purpose: Due to increasing interest in the treatment of spinal cord injuries, many histopathological studies have been conducted to prove that many neurotrophic factors including growth hormone are important for regeneration of the injured spinal cord. Growth hormone has to be given everyday, however, and this negatively affects compliance in clinical trials. Recently, the invention of sustained release growth hormone (SRGH) that can be given just once a week may both help the regeneration of injured spinal cord and, at the same time, be more compliant and convenient for clinical patients. Methods: In this study, thirty 7-week-old female Spraque-Dawley rats were subjected to a weight-driven impact spinal cord injury. They were divided into 3 groups and Group I and II were injected with SRGH once a week for 4 weeks; Group I were injected into the injured spinal cord area, while Group II were injected into the peritoneal cavity. Meanwhile, Group III were injected with normal saline solution. The functional outcome was evaluated using the Basso-Beattie-Bresnahan motor rating score and the inclined plane test was done 4 weeks after the first injection. Histopathological examination was performed at the same time and the amount of residual white matter was measured in all groups. Results: After 4 weeks, Groups I and II showed greater improvement than Group III(the control group) in the functional test. In the control group, invasion of atypical phagocytes, axonal degeneration, edema and cavity formation in the posterior site of spinal cord gray matter was observed in histopatholgical examination. The rate of residual white matter in Group III was less than in the other groups. Conclusion: Data showed significant functional and histopathological improvement in the groups treated with SRGH into the spinal and peritoneal cavity compared with the control group. SRGH is therefore beneficial because it helps with regeneration of the injured spinal cord and improves the compliance and convenience of patients.
Keywords
Sustained release growth hormone; Spinal cord injury;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH: Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci 17: 5560, 1997
2 Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR: Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164: 247, 2000   DOI   ScienceOn
3 Coculescu M: Blood-brain barrier for human growth hormone and insulin-like growth factor-I. J Pediatr Endocrinol Metab 12: 113, 1999
4 Guan J, Bennet L, Gluckman PD, Gunn AJ: Insulin- like growth factor-1 and post-ischemic brain injury. Prog Neurobiol 70: 443, 2003   DOI   ScienceOn
5 Lu P, Jones LL, Snyder EY, Tuszynski MH: Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181: 115, 2003   DOI   ScienceOn
6 Zhou L, Baumgartner BJ, Hill-Felberg SJ, McGowen LR, Shine HD: Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord. J Neurosci 23: 1424, 2003
7 Wrathall JR, Pettegrew RK, Harvey F: Spinal cord contusion in the rat: production of graded, reproducible, injury groups. Exp Neurol 88: 108, 1985   DOI   ScienceOn
8 Blesch A, Uy HS, Grill RJ, Cheng JG, Patterson PH, Tuszynski MH: Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury. J Neurosci 19: 3556, 1999
9 Kakulas BA: Neuropathology: the foundation for new treatments in spinal cord injury. Spinal Cord 42: 549, 2004   DOI   ScienceOn
10 Basso DM, Beattie MS, Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12: 1, 1995   DOI   ScienceOn
11 An RZ, Yu JH, Song KS: The Neuroprotective effect of growth hormone on neuronal injury of brain in pilocarpine induced status epilepticus. J Korean Soc Endocrinol 16: 26, 2001
12 Scheepens A, Sirimanne ES, Breier BH, Clark RG, Gluckman PD, Williams CE: Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience 104: 677, 2001   DOI   ScienceOn
13 Liu Y, Kim D, Himes BT, Chow SY, Schallert T, Murray M, Tessler A, Fischer I: Transplants of fibroblasts genetically modified to express brain- derived neurotrophic factor promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci 19: 4370, 1999
14 Blesch A, Lu P, Tuszynski MH: Neurotrophic factors, gene therapy and neural stem cells for spinal cord repair. Brain Res Bull 57: 833, 2002   DOI   ScienceOn